Abattis Bioceuticals Corp. (ATTBF)

0.0000 0.0000 (0.00%) At close: 02:36PM EDT

Abattis Bioceuticals Corp.

625 Howe Street
Suite 1200
Vancouver, BC V6C 2M6
Canada
808 650 3007
https://www.abattis.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Robert J. Abenante BBA, CA, MPAcc	President, CEO & Director	274.85k	N/A	1983
Mr. Francesco Paolini	CFO & Director	N/A	N/A	N/A
Mr. Patrick Mitchell	COO & Director	N/A	N/A	N/A
Mr. Shawn Balaghi	Head of Corporate Development	N/A	N/A	N/A
Mr. Jim Carter	Head of Mergers and Acquisitions Advisory	N/A	N/A	N/A
Mr. Christopher P. Cherry C.A., CPA, CA, CGA, CPA	Corporate Comptroller	N/A	N/A	1979
Ms. Nicole Breitinger	Corporate Secretary	N/A	N/A	N/A

Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.

Corporate Governance

Abattis Bioceuticals Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.